Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Stuart J. Swiedler, J. E. Wraith et al.|The Journal of Pediatrics|2006Cited by 364
Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS IEmil Kakkis, Merry Passage, Michael F. McEntee et al.|Molecular Genetics and Metabolism|2004Cited by 168
Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluidPatricia Dickson, Emil Kakkis, Merry Passage et al.|Molecular Genetics and Metabolism|2007Cited by 162